Site US1118 — Lewiston, Maine

Site US1118 is a clinical research site located in Lewiston, Maine, United States 04240.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site US1118 has participated in 1 clinical trials.

Therapeutic areas: Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Prostate Cancer.

Sponsors: Astellas Pharma Global Development, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lewiston

Browse all research sites in Maine · View every site in Lewiston

• Central Maine Medical Center
• Central Maine Eye Care
• Central Maine Comprehensive Cancer Center at Central Maine Medical Center
• Saint Mary's Regional Medical Center
• Research Site
• Maine Research Associates
• GSK Investigational Site
• Central Maine Heart & Vascular Institute
• Community Clinical Services
• Maine Research Associates - Lewiston
• Investigational Site
• Central Maine Medical Center, Bennett Breast Care Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US1118?

Site US1118 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US1118 conducted?

Site US1118 has 1 clinical trials on record. Their work covers Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Prostate Cancer.

Is Site US1118 accredited by Crixeo Clinical Trials?

Site US1118 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US1118?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.